Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    50,372.52
    -1,067.16 (-2.07%)
     
  • CMC Crypto 200

    1,304.48
    -92.06 (-6.59%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Facebook surges to new high, Priceline CEO steps down

Here are some of the stocks the Yahoo Finance team will be watching for you today.

Facebook (FB) shares hit a new all-time high in early in early trading after the social media giant's first-quarter revenue rose over 50%, crushing Wall Street expectations. The big beat comes as the company brought on new advertisers with its popular mobile app and live video feature. Facebook also announced a new shareholding structure designed to keep CEO Mark Zuckerberg in control.

Ford (F) delivered earnings and revenue that raced past analysts' estimates as net income more than doubled to $2.5 billion for the first quarter driven by strong sales of trucks and SUVs, which helped propel revenue to record levels in North America.  

Amazon (AMZN) is set to report first-quarter results after the close of trading today. Analysts are looking for Amazon to swing to a profit of $0.58 a share, compared to $0.12 loss last year. Revenue is projected to jump 23% to about $28 billion.

Priceline CEO's abrupt exit

Priceline's (PCLN) CEO Darren Huston is stepping down following a board-led investigation "surrounding a personal relationship with an employee." Priceline has appointed former CEO and current chairman Jeffery Boyd as interim chief executive as it searches to find a successor.

ADVERTISEMENT

Drug deals

St. Jude Medical (STJ) shares soared in early trading. Abbott Labs (ABT) is buying the medical device maker in a deal valued at $25 billion dollars. Abbott expects the deal to add significantly to earnings beginning in 2017.

Medivation (MDVN) shares rose sharply in early trading. French drug maker Sanofi made an unsolicited offer to buy the U.S. biotech firm after previous attempts failed. The all-cash deal is valued at $9.3 billion and would help Sanofi expand its cancer treatment business.